Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Breast Cancer. 2019 May 24;19(4):e495–e500. doi: 10.1016/j.clbc.2019.05.009

Figure 1:

Figure 1:

Overall survival for metaplastic breast cancer.

Overall survival is shown for patients treated with conventional adjuvant therapy or platinum/taxane chemotherapy. Two patients treated with conventional therapy did not receive chemotherapy.

*One patient who received conventional therapy died without cancer recurrence.